Centessa Pharmaceuticals Plc ADR (CNTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -79,241 | -197,532 | -131,369 | -76,478 | -26,135 |
| Depreciation Amortization | 584 | 2,076 | 1,556 | 1,048 | 529 |
| Income taxes - deferred | 828 | 2,509 | 2,276 | 2,021 | 995 |
| Accounts payable and accrued liabilities | 3,263 | 50 | 1,362 | -1,918 | -2,095 |
| Other Working Capital | -5,771 | -30,030 | -31,250 | -19,986 | -38,436 |
| Other Operating Activity | 8,113 | 29,110 | 19,415 | 15,615 | 7,896 |
| Operating Cash Flow | $-72,224 | $-193,817 | $-138,010 | $-79,698 | $-57,246 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 42,707 | -418,160 | -200,037 | -262,216 | -222,388 |
| PPE Investments | N/A | -371 | -360 | -126 | N/A |
| Investing Cash Flow | $42,707 | $-418,531 | $-200,397 | $-262,342 | $-222,388 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 34,121 | 296,720 | 13,139 | 9,577 | 7,872 |
| Other Financing Activity | -3,654 | -5,192 | -5,011 | -4,886 | -4,786 |
| Financing Cash Flow | $30,467 | $291,528 | $8,128 | $4,691 | $3,086 |
| Exchange Rate Effect | 182 | -448 | -2,131 | -1,630 | -1,517 |
| Beginning Cash Position | 61,953 | 383,221 | 383,221 | 383,221 | 383,221 |
| End Cash Position | 63,085 | 61,953 | 50,811 | 44,242 | 105,156 |
| Net Cash Flow | $1,132 | $-321,268 | $-332,410 | $-338,979 | $-278,065 |
| Free Cash Flow | |||||
| Operating Cash Flow | -72,224 | -193,817 | -138,010 | -79,698 | -57,246 |
| Capital Expenditure | N/A | -371 | -360 | -126 | N/A |
| Free Cash Flow | -72,224 | -194,188 | -138,370 | -79,824 | -57,246 |